SEC Form 4 · accession 0001562180-17-001135

PROGENICS PHARMACEUTICALS INC · PGNX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CFO

Period of report

Mar 1, 2017

Accepted (ET)

Mar 7, 2017 · 11:35 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000835887

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (Right to Buy)^F1	$11.32	Mar 1, 2017	A	82,500	A	—	Mar 1, 2027	Common Stock	82,500	82,500	D